Table 2

Clinical Outcomes After 2 Years in the As-Treated Population

TAVR GroupSurgical Groupp Value
All-cause death85 (22.2)99 (28.6)0.04
 Cardiovascular death58 (15.4)64 (19.4)0.19
Stroke40 (10.9)52 (16.6)0.05
 Major25 (6.8)30 (9.8)0.25
 Minor15 (4.2)23 (7.3)0.08
 TIA9 (2.6)5 (1.6)0.41
Death or major stroke93 (24.2)113 (32.5)0.01
Myocardial infarction7 (1.9)7 (2.3)0.83
Major vascular complication27 (7.1)7 (2.0)0.001
Life-threatening or disabling bleeding69 (18.1)140 (39.6)<0.001
Major bleeding123 (32.3)135 (38.2)0.07
Acute kidney injury24 (6.2)54 (15.1)<0.001
Permanent pacemaker implantation96 (25.8)42 (12.8)<0.001
New-onset or worsening atrial fibrillation71 (19.5)121 (34.9)<0.001

Values are n (%). All data reported as Kaplan-Meier estimates at the specific time point and do not equal the number of patients with events divided by the total number of patients in each treatment group. p values were calculated by using the log-rank test for all data through 2 years.

Abbreviations as in Table 1.